Autoimmunity to antigens of the central nervous system is usually considered detrimental. T cells specific to a central nervous system self antigen, such as myelin basic protein, can indeed induce experimental autoimmune encephalomyelitis, but such T cells may nevertheless appear in the blood of healthy individuals. We show here that autoimmune T cells specific to myelin basic protein can protect injured central nervous system neurons from secondary degeneration. After a partial crush injury of the optic nerve, rats injected with activated anti–myelin basic protein T cells retained approximately 300% more retinal ganglion cells with functionally intact axons than did rats injected with activated T cells specific for other antigens. Electrophysiological analysis confirmed this finding and suggested that the neuroprotection could result from a transient reduction in energy requirements owing to a transient reduction in nerve activity. These findings indicate that T–cell autoimmunity in the central nervous system, under certain circumstances, can exert a beneficial effect by protecting injured neurons from the spread of damage.
This is a preview of subscription content, access via your institution
Open Access articles citing this article.
Seminars in Immunopathology Open Access 04 July 2022
Journal of Neuroinflammation Open Access 13 November 2021
Injury intensifies T cell mediated graft-versus-host disease in a humanized model of traumatic brain injury
Scientific Reports Open Access 01 July 2020
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
Prices may be subject to local taxes which are calculated during checkout
Streilein, J.W. Immune privilege as the result of local tissue barriers and immunosuppressive microenvironments. Curr. Opin. Immunol. 5, 428–432 (1993).
Streilein, J.W. Unraveling immune privilege. Science 270, 1158–1159 (1995).
Lazarov Spiegler, O. et al. Transplantation of activated macrophages overcomes central nervous system regrowth failure. FASEB J. 10, 1296–1302 (1996).
Rapalino, O. et al. Implantation of stimulated homologous macrophages results in partial recovery of paraplegic rats. Nature Med. 4, 814–821 (1998).
Hickey, W.F., Hsu, B.L. & Kimura, H. T7–lymphocyte entry into the central nervous system. J. Neurosci. Res. 28, 254– 260 (1991).
Ben Nun, A., Wekerle, H. & Cohen, I.R. The rapid isolation of clonable antigen–specific T lymphocyte lines capable of mediating autoimmune encephalomyelitis. Eur. J. Immunol. 11, 195–199 (1981).
Ota, K. et al. T–cell recognition of an immunodominant myelin basic protein epitope in multiple sclerosis. Nature 346, 183–187 (1990).
Martin, R. Immunological aspects of experimental allergic encephalomyelitis and multiple sclerosis and their application for new therapeutic strategies. J. Neural Transm. Suppl. 49, 53–67 (1997).
Burns, J., Rosenzweig, A., Zweiman, B. & Lisak, R.P. Isolation of myelin basic protein–reactive T–cell lines from normal human blood. Cell. Immunol. 81, 435– 440 (1983).
Pette, M. et al. Myelin autoreactivity in multiple sclerosis: recognition of myelin basic protein in the context of HLA–DR2 products by T lymphocytes of multiple–sclerosis patients and healthy donors. Proc. Natl. Acad. Sci. USA 87, 7968–7972 (1990).
Martin, R. et al. Fine specificity and HLA restriction of myelin basic protein–specific cytotoxic T cell lines from multiple sclerosis patients and healthy individuals. J. Immunol. 145, 540–548 (1990).
Schluesener, H.J. & Wekerle, H. Autoaggressive T lymphocyte lines recognizing the encephalitogenic region of myelin basic protein: in vitro selection from unprimed rat T lymphocyte populations. J. Immunol. 135, 3128–3133 (1985).
Hirschberg, D.L. et al. Accumulation of passively transferred primed T cells independently of their antigen specificity following central nervous system trauma. J. Neuroimmunol. 89, 88–96 (1998).
Faden, A.I. & Salzman, S. Pharmacological strategies in CNS trauma. Trends Pharmacol. Sci. 13, 29– 35 (1992).
Faden, A.I. Experimental neurobiology of central nervous system trauma. Crit. Rev. Neurobiol. 7, 175–186 (1993).
McIntosh, T.K. Novel pharmacologic therapies in the treatment of experimental traumatic brain injury: a review. J. Neurotrauma 10, 215 –261 (1993).
Lynch, D.R. & Dawson, T.M. Secondary mechanisms in neuronal trauma. Curr. Opin. Neurol. 7, 510– 516 (1994).
Bazan, N.G., Rodriguez de Turco, E.B. & Allan, G. Mediators of injury in neurotrauma: intracellular signal transduction and gene expression. J. Neurotrauma 12, 791–814 (1995).
Liu, D., Yang, R., Yan, X. & McAdoo, D.J. Hydroxyl radicals generated in vivo kill neurons in the rat spinal cord: electrophysiological, histological, and neurochemical results. J. Neurochem. 62, 37–44 (1994).
Yoshino, A., Hovda, D.A., Kawamata, T., Katayama, Y. & Becker, D.P. Dynamic changes in local cerebral glucose utilization following cerebral concussion in rats: evidence of a hyper– and subsequent hypometabolic state. Brain Res. 561, 106–119 (1991).
Hovda, D.A., Yoshino, A., Kawamata, T., Katayama, Y. & Becker, D.P. Diffuse prolonged depression of cerebral oxidative metabolism following concussive brain injury in the rat: a cytochrome oxidase histochemistry study. Brain Res. 567, 1–10 (1991).
Zivin, J.A. & Choi, D.W. Stroke therapy. Sci. Am. 265, 56–63 ( 1991).
Yoles, E. et al. GM1 reduces injury–induced metabolic deficits and degeneration in the rat optic nerve. Invest. Ophthalmol. Vis. Sci. 33, 3586–3591 (1992).
Yoles, E. & Schwartz, M. N–methyl–D–aspartate–receptor antagonist protects neurons from secondary degeneration after partial optic nerve crush. J. Neurotrauma 14, 665– 675 (1997).
Yoles, E. & Schwartz, M. Degeneration of spared axons following partial white matter lesion: Implications for optic nerve neuropathies. Exp. Neurol. 153, 1–7 ( 1998).
Naparstek, Y. et al. T lymphocyte lines producing or vaccinating against autoimmune encephalomyelitis (EAE). Functional activation induces peanut agglutinin receptors and accumulation in the brain and thymus of line cells. Eur. J. Immunol. 13, 418–423 ( 1983).
Popovich, P.G., Stokes, B.T. & Whitacre, C.C. Concept of autoimmunity following spinal cord injury: possible roles for T lymphocytes in the traumatized central nervous system. J. Neurosci. Res. 45, 349– 363 (1996).
Mor, F. & Cohen, I.R. Pathogenicity of T cells responsive to diverse cryptic epitopes of myelin basic protein in the Lewis rat. J. Immunol. 155, 3693–3699 (1995).
Savio, T. & Schwab, M.E. Rat CNS white matter, but not gray matter, is nonpermissive for neuronal cell adhesion and fiber outgrowth. J. Neurosci. 9, 1126–1133 (1989).
Lotan, M. & Schwartz, M. Cross talk between the immune system and the nervous system in response to injury: implications for regeneration. FASEB J. 8, 1026–1033 (1994).
Zamvil, S.S. & Steinman, L. The T lymphocyte in experimental allergic encephalomyelitis. Annu. Rev. Immunol. 8, 579–621 (1990).
Palladini, G., Grossi, M., Maleci, A., Lauro, G.M. & Guidetti, B. Immunocomplexes in rat and rabbit spinal cord after injury. Exp. Neurol. 95, 639– 651 (1987).
Mizrachi, Y. et al. Systemic humoral factors participating in the course of spinal cord injury. Paraplegia 21, 287– 293 (1983).
Cohen, I.R. Autoimmunity to chaperonins in the pathogenesis of arthritis and diabetes. Annu. Rev. Immunol. 9, 567– 589 (1991).
Mor, F. & Cohen, I.R. T cells in the lesion of experimental autoimmune encephalomyelitis. Enrichment for reactivities to myelin basic protein and to heat shock proteins. J. Clin. Invest. 90, 2447–2455 (1992).
Ransom, B.R., Stys, P.K. & Waxman, S.G. The pathophysiology of anoxic injury in central nervous system white matter. Stroke 21, 11 (suppl), III52–57 (1990).
Barone, F.C., Feuerstein, G.Z. & White, R.F. Brain cooling during transient focal ischemia provides complete neuroprotection. Neurosci. Biobehav. Rev. 21, 31–44 (1997).
Yarom, Y. et al. Immunospecific inhibition of nerve conduction by T lymphocytes reactive to basic protein of myelin. Nature 303, 246–247 (1983).
Koller, H., Siebler, M. & Hartung, H.P. Immunologically induced electrophysiological dysfunction: implications for inflammatory diseases of the CNS and PNS. Prog. Neurobiol. 52, 1–26 ( 1997).
Meeson, A.P., Piddlesden, S., Morgan, B.P. & Reynolds, R. The distribution of inflammatory demyelinated lesions in the central nervous system of rats with antibody–augmented demyelinating experimental allergic encephalomyelitis. Exp. Neurol. 129, 299 –310 (1994).
Ehrhard, P.B., Erb, P., Graumann, U. & Otten, U. Expression of nerve growth factor and nerve growth factor receptor tyrosine kinase Trk in activated CD4–positive T–cell clones. Proc. Natl. Acad. Sci. USA 90, 10984–10988 ( 1993).
Lambiase, A. et al. Human CD4+ T cell clones produce and release nerve growth factor and express high–affinity nerve growth factor receptors. J. Allergy Clin. Immunol. 100, 408– 414 (1997).
Santambrogio, L. et al. Nerve growth factor production by lymphocytes. J. Immunol. 153, 4488–4495 (1994).
Cohen, I.R. The cognitive paradigm and the immunological homunculus. Immunol. Today 13, 490–494 ( 1992).
Lider, O., Reshef, T., Beraud, E., Ben Nun, A. & Cohen, I.R. Anti–idiotypic network induced by T cell vaccination against experimental autoimmune encephalomyelitis. Science 239, 181–183 (1988).
Matzinger, P. Tolerance, danger, and the extended family. Annu. Rev. Immunol. 12, 991–1045 ( 1994).
Hirshfeld, H., Teitelbaum, D., Arnon, R. & Sela, M. Basic encephalitogenic protein: a simplified purification on sulfoethyl–Sephadex. FEBS Lett. 7, 317 ( 1970).
Elias, D. et al. Vaccination against autoimmune mouse diabetes with a T–cell epitope of the human 65–kDa heat shock protein. Proc. Natl. Acad. Sci. USA 88, 3088–3091 (1991).
Mor, F. & Cohen, I.R. Shifts in the epitopes of myelin basic protein recognized by Lewis rat T cells before, during, and after the induction of experimental autoimmune encephalomyelitis. J. Clin. Invest. 92, 2199–2206 ( 1993).
Gillis, S., Ferm, M.M., Ou, W. & Smith, K.A. T cell growth factor: parameters of production and a quantitative microassay for activity. J. Immunol. 120, 2027– 2032 (1978).
Duvdevani, R. et al. Graded crush of the rat optic nerve as a brain injury model: combining electrophysiological, histological and behavioral outcome. Restor. Neurol. Neurosci. 2, 31–38 (1990).
Hunig, T., Wallny, H.J., Hartley, J.K., Lawetzky, A. & Tiefenthaler, G. A monoclonal antibody to a constant determinant of the rat T cell antigen receptor that induces T cell activation. Differential reactivity with subsets of immature and mature T lymphocytes. J. Exp. Med. 169, 73– 86 (1989).
Yoles, E., Belkin, M. & Schwartz, M. HU–211, a nonpsychotropic cannabinoid, produces short– and long–term neuroprotection after optic nerve axotomy. J. Neurotrauma 13, 49– 57 (1996).
We thank S. Smith and P. Taylor for editorial assistance, and I. Friedmann for help with graphics. I.R. Cohen is the incumbent of the Mauerberger Chair in Immunology, the director of the Robert Koch–Minerva Center for Research in Autoimmune Disease and the director of the Center for the Study of Emerging Diseases. M.S. holds the Maurice and Ilse Katz Professorial Chair in Neuroimmunology.
About this article
Cite this article
Moalem, G., Leibowitz–Amit, R., Yoles, E. et al. Autoimmune T cells protect neurons from secondary degeneration after central nervous system axotomy. Nat Med 5, 49–55 (1999). https://doi.org/10.1038/4734
This article is cited by
Nature Neuroscience (2023)
Temporal single-cell atlas of non-neuronal retinal cells reveals dynamic, coordinated multicellular responses to central nervous system injury
Nature Immunology (2023)
Neuroimaging is the new “spatial omic”: multi-omic approaches to neuro-inflammation and immuno-thrombosis in acute ischemic stroke
Seminars in Immunopathology (2023)
Seminars in Immunopathology (2022)